A
B
C
D
E
F
G
H
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

A

 Al Benson
TBD
播放:365
Current Standard Practice after ASCO 2018 Colorectal Cancer

G

郭军
郭军
北京大学肿瘤医院
播放:84
讨论-9
播放:84
专家评述-9
播放:35
讨论-8

J

江泽飞
江泽飞
中国人民解放军307医院
播放:242
Current Standard Practice after ASCO 2018 Breast Cance
播放:130
讨论-6

L

李进
李进
上海东方医院
播放:162
讨论-11
李宁
李宁
中国医学科学院肿瘤医院
播放:47
Abstract 5506 Chemotherapy plus or minus bevacizumab for platinum-sensitive ovarian cancer patients recurring after a bevacizumab containing first line treatment The randomized phase 3 trial MITO16B-MaNGO OV2B-ENGOT OV17.
播放:33
Abstract 5505 Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma A phase III GOG study.
播放:45
Abstract 5500 Comparison of survival between upfront primary debulking surgery versus neoadjuvant chemotherapy for stage IIIIV ovarian, tubal and peritoneal cancers in phase III randomized trial JCOG0602.
廖宁
廖宁
广东省人民医院
播放:52
讨论-5
播放:53
Abstract 506 PERSEPHONE 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC) Randomised phase 3 non-inferiority trial with definitive 4-year (yr) disease-free survival (DFS) results.
播放:48
Abstract 104 Randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC).
播放:78
Abstract 104 Randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC).
刘秀峰
刘秀峰
中国人民解放军第八一医院
播放:99
Abstract 4019 Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib Results from the randomized phase 3 CELESTIAL trial.
播放:56
Abstract 4003 REACH-2 A randomized, double-blind, placebo-controlled phase 3 study of ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP) following firs
播放:47
Abstract 4004 A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors A trial of the ECOG-ACRIN Cancer Research Group (E2211).
播放:56
Abstract LBA 4002 Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1) A randomized, controlled, multicenter phase III trial.
播放:67
Abstract LBA4001 Unicancer GI PRODIGE 24CCTG PA.6 trial A multicenter international randomized controlled phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas

M

 Manish Shah
TBD
播放:116
Current Standard Practice after ASCO 2018: Gastric cancer
播放:94
专家评述-11
孟志强
孟志强
复旦大学附属肿瘤医院(上海市肿瘤医院上海市红十字肿瘤医院)
播放:93
专家评述-7

P

 Pasi Janne
TBD
播放:168
Current Standard Practice after ASCO 2018 Lung Cancer

Q

秦叔逵
秦叔逵
中国人民解放军第八一医院
播放:270
闭幕致辞
播放:59
讨论-7

W

王峰
王峰
中山大学肿瘤防治中心(附属肿瘤医院、肿瘤研究所)
播放:111
Abstract 3506 Plasma HER2 (ERBB2) copy number to predict response to HER2-targeted therapy in metastatic colorectal cancer.
播放:81
Abstract 3505 First-line FOLFOX plus panitumumab followed by 5-FULV plus panitumumab or single-agent panitumumab as maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC) The VALENTINO study.
播放:74
Abstract LBA 3503 A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC) PRODIGE 7.
王树森
王树森
中山大学附属防治中心
播放:61
Abstract 1007 AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT) A randomised, double-blind, placebo-controlled, phase II trial.
播放:56
Abstract 1005 Everolimus (EVE) + Exemestane (EXE) vs EVE Alone or Capecitabine (CAP) for Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2-negative (HER2-) Advanced Breast Cancer (ABC) BOLERO-6, an Open-label Phase 2 Study.
播放:67
Abstract LBA 1006 Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-mutant (MUT), locally advanced or metastatic breast cancer (MBC) Primary analysis from SANDPIPER.
王晓稼
王晓稼
浙江省肿瘤医院
播放:68
专家评述-6
吴令英
吴令英
中国医学医学院肿瘤医院
播放:36
讨论-10
吴小华
吴小华
复旦大学附属肿瘤医院(上海市肿瘤医院上海市红十字肿瘤医院)
播放:74
专家评述-10

X

徐瑞华
徐瑞华
中山大学肿瘤防治中心(附属肿瘤医院、肿瘤研究所)
播放:127
讨论-12
播放:99
专家评述-12

Y

姚旭东
姚旭东
上海市第十人民医院
播放:38
Abstract 5001 68Ga-PSMA11 PETCT localizes recurrent prostate cancer with high accuracy Preliminary results from a phase 23 prospective trial.
播放:33
Abstract LBA 3 CARMENA Cytoreductive nephrectomy followed by sunitinib versus sunitinib alone in metastatic renal cell carcinoma—Results of a phase III noninferiority trial.
播放:35
Abstract 4511 Patient-reported outcomes (PROs) in IMmotion151 atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun) in treatment (tx) naive metastatic renal cell carcinoma (mRCC).
殷咏梅
殷咏梅
江苏省人民医院(南京医科大学第一附属医院)
播放:108
专家评述-5
袁响林
袁响林
华中科技大学同济医学院附属同济医院
播放:93
Abstract 4062 Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (GGEJ) cancer Phase 3 KEYNOTE-061 trial
播放:58
Abstract 4007 A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial).
播放:53
Abstract LBA 4008 Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy Efficacy and safety in the phase III randomized factorial ASPECT trial.

Z

张晓实
张晓实
中山大学肿瘤防治中心
播放:37
专家评述-8
朱波
朱波
新桥医院(第三军医大学第二附属医院)
播放:51
Abstract 3006 NKTR-214 (CD122-biased agonist) plus nivolumab in patients with advanced solid tumors Preliminary phase 12 results of PIVOT.
播放:37
Abstract 3000 ICONIC Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011 +- nivolumab (nivo) in patients (pts) with advanced cancers.
播放:46
Abstract 9502 Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIIV melanoma Updated results from a phase III trial (CheckMate 238).

首页

视频

会议

我的